NCT00110760View on ClinicalTrials.gov

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Pain
Interventions
DRUG

S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)

S-Caine Peel was composed of a 1:1 eutectic mixture of 7% lidocaine and 7% tetracaine and was applied topically. S-Caine Peel was applied with a uniform thickness of approximately 1 mm and remained on the treatment area for 30 minutes (+/- 2 minutes).

DRUG

Placebo Peel

Placebo Peel applied topically with a uniform thickness of approximately 1 mm and remained on the treatment area for 30 minutes (+/- 2 minutes).

Trial Locations (3)

37215

Tennessee Clinical Research Center, Nashville

77802

J&S Studies, Inc., Bryan

80113

AboutSkin Dermatology, Englewood

All Listed Sponsors
lead

ZARS Pharma Inc.

INDUSTRY